• Safety & Recalls
  • Regulatory Updates
  • Drug Coverage
  • COPD
  • Cardiovascular
  • Obstetrics-Gynecology & Women's Health
  • Ophthalmology
  • Clinical Pharmacology
  • Pediatrics
  • Urology
  • Pharmacy
  • Idiopathic Pulmonary Fibrosis
  • Diabetes and Endocrinology
  • Allergy, Immunology, and ENT
  • Musculoskeletal/Rheumatology
  • Respiratory
  • Psychiatry and Behavioral Health
  • Dermatology
  • Oncology

BlueCross BlueShield of Tennessee to Cover COVID-19 Booster


The plan will cover administration of the booster for those with cancer or who are immunocompromised.

BlueCross BlueShield of Tennessee will cover the administration cost for a COVID-19 booster for those who are moderately to severely immunocompromised, including those undergoing cancer treatment. Organization executives said in a statement that members in commercial Blue Network S, P and L, as well as Medicare Advantage, BlueCare Tennessee and BlueCare Plus Tennessee will also be able to get a booster without any out-of-pocket costs.

Andrea Willis, M.D.

Andrea Willis, M.D.

“It’s our responsibility to support members seeking to protect themselves against COVID-19. Research has demonstrated the clear value of a booster to reduce risk, which ultimately will help communities facing the Delta variant surge,” Andrea Willis, M.D., chief medical officer for BlueCross.

The Centers for Disease Control recommends COVID-19 vaccine boosters for those who:

  • Are receiving active cancer treatment for tumors or cancers of the blood
  • Received an organ transplant and are taking medicine to suppress the immune system
  • Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
  • Have a moderate or severe primary immunodeficiency
  • Have an advanced or untreated HIV infection
  • Are undergoing active treatment with high-dose corticosteroids or other drugs that may suppress their immune response

Additional, the plan is waiving member costs for medically necessary COVID-19 testing until the end of the national public health emergency, and last year made permanent coverage for in-network telehealth visits for members with employer-based or individual plans.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.